Tanuxiciclib
Tanuxiciclib is a cyclin dependent kinase (CDK) inhibitor[1].
Product Specifications
CAS Number
[1983983-64-7]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanuxiciclib.html
Purity
98.0
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N
Molecular Formula
C15H13FN6O
Molecular Weight
312.30
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SIPC926Hu01-01 10 µg
Recombinant Carcinoembryonic Antigen Related Cell Adhesion Molecule 8 (CEACAM8)
Ask
View Details 
SIPC926Hu01-02 50 µg
Recombinant Carcinoembryonic Antigen Related Cell Adhesion Molecule 8 (CEACAM8)
Ask
View Details SIPC926Hu01-03 200 µg
Recombinant Carcinoembryonic Antigen Related Cell Adhesion Molecule 8 (CEACAM8)
Ask
View Details SIPC926Hu01-04 1 mg
Recombinant Carcinoembryonic Antigen Related Cell Adhesion Molecule 8 (CEACAM8)
Ask
View Details SIPC926Hu01-05 5 mg
Recombinant Carcinoembryonic Antigen Related Cell Adhesion Molecule 8 (CEACAM8)
Ask
View Details